In this study, we found that reducing SYNGR4 expression leads to a shift in tumor-associated macrophages towards the M1 (pro-inflammatory) phenotype in breast cancer, potentially aiding in the reversal of the anti-inflammatory tumor immune microenvironment. This evidence concerns the gene SYNGR4 and breast cancer.